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INTRODUCTION
Inguinal hernia is a very common problem in the general population 
with a very high incidence. In fact, inguinal hernia is most common type of 
hernia.  As  a  result  of  this  high  incidence,  inguinal  herniorraphy  or 
hernioplasty  is  a  commonly  performed  procedure.  Hence,  the  plan  of 
anaesthesia becomes very important. Most of the cases are done as a day-
care procedure or with just one day of in-hospital stay and ideally, the plan 
of anaesthesia should be with the aim of quicker recovery, minimum side 
effects, maximum pain relief and good patient satisfaction. So, towards this 
end, a comparative  study was done between local anaesthesia and general 
anaesthesia.
AIM OF THE STUDY
The aim of this study is to compare the differences between local and 
general anaesthesia for inguinal hernia repair by comparing intra-op  
hemodynamic  parameters,  recovery  profiles,  post-op  pain  relief,  post-op 
pain satisfaction, and post-op side effects.
ANATOMY OF THE INGUINAL REGION
An inguinal hernia is the protrusion of part of the contents of the 
abdomen  through the inguinal region of the abdominal wall.  The inguinal 
region is a  weak part of the abdominal wall due to the presence of the 
inguinal canal, the deep inguinal ring and the superficial inguinal ring.
The inguinal  canal  -  The  inguinal  canal  is  a  triangular  slit  almost 
horizontal in direction which lies just above the inner half of the inguinal 
ligament.  It commences at the deep inguinal ring and ends at the superficial 
inguinal ring.  In infants, the superficial and deep inguinal rings are almost 
superimposed and the obliquity of this canal is slight.  In adults, the inguinal 
canal is about 3.75 cm long and is directed downwards and medially from 
the deep to  the  superficial  inguinal  ring.  This  canal  develops  due to  the 
descent of testis in the embryonic life.
The deep inguinal ring  -  It is an opening in the fascia transversalis 1.25 
cm above the mid-inguinal point, i.e., midpoint between the symphysis pubis 
and the anterior superior iliac spine.  It is oval in shape, the long  axis being 
vertical.  It varies in size in different individuals and is much larger in the 
male  than  in  the  female.   At  its  margins,  the  fascia  transversalis  is 
condensed.   Medially,  it  is  related  to  the  inferior  epigastric  vessels.   It 
transmits the spermatic cord in the male and round ligament of the uterus in 
the female.
The superficial inguinal ring  -  It is an interval in the aponeurosis of 
the external oblique muscle.  It is situated just above and lateral to the crest 
of  the  pubis.   The  aperture  is  somewhat  triangular  with  its  long  axis 
corresponding to the course of  the fibres of the aponeurosis.   Its  base is 
formed by the crest of the pubis and its sides by the margins of the opening 
of the aponeurosis which are called the crura of the ring.  The superficial 
inguinal ring gives passage to the spermatic cord and the ilio-inguinal nerve 
in the male and to the round ligament of the uterus and the ilio-inguinal 
nerve in case of females.
Exposure of the inguinal region 
Boundaries of the inguinal canal
Anteriorly   -  throughout its whole length there are skin, the superficial 
fascia and the aponeurosis of the external oblique and in its lateral 1/3 rd there 
are the fleshy fibres of the origin of the internal oblique.
Posteriorly  -  the transversalis fascia along the whole length of the canal 
separates it from the extraperitoneal connective tissue and the peritoneum. 
In  the  medial  half  there  is  the  conjoined  tendon  
( combination of internal oblique and transverses muscles )  and reflected 
part of the inguinal ligament.
Above  -  there are arched fibres of the internal oblique and transverses 
abdominis before they fuse to form the conjoined tendon.
Below  -  the floor is formed by the grooved upper surface of the inguinal 
ligament and its union with fascia transversalis.  At its medial end there is 
lacunar ligament.
Contents of the inguinal canal
 Ilio-inguinal nerve which enters the inguinal canal in its medial half 
by piercing the internal oblique muscle and lies below the spermatic 
cord to accompany it through the superficial inguinal ring.
 In males, spermatic cord and its coverings, internal spermatic fascia, 
cremasteric fascia and external spermatic fascia.
 In females, round ligament of uterus.
Structures of the spermatic cord
 Vas deferens
 Arteries of the spermatic cord – testicular artery, artery of the vas 
deferens and artery to the cremaster
 Pampiniform plexus of testicular veins
 Lymph vessels of the testis
 Nerves – testicular  plexus of sympathetic  nerves which accompany 
the testicular artery and artery of the ductus deferens and the genital 
branch  of the genitofemoral nerve
ANATOMY OF THE NERVES IN THE 
INGUINAL REGION
Innervation of inguinal region is by 11th and 12th thoracic nerves and 1st and 
2nd lumbar somatic nerves  -  
• Ilioinguinal nerve (L1)
• Iliohypogastric nerve (T12,L1)
• Genitofemoral nerve (L1,L2)
Some fibres from T11 above and some fibres crossing the midline.
Innervation of the spermatic cord  -  
• Genital  branch  of  genitofemoral  nerve  and  testicular  plexus  of 
sympathetic nerves from thoracic sympathetic outflow.
Formation of the lumbar plexus
The plexus assembles in front of the transverse processes of the 
lumbar vertebrae within the substance of the psoas major.  L1, joined in 50% 
of cases by a branch from T12, divides into an upper and lower division. 
The upper division gives rise to the iliohypogastric and ilioinguinal nerves; 
the lower joins a branch from L2 to form the genitofemoral nerve.  The rest 
of L2, together with L3 and the contribution to the plexus from L4, divide 
into dorsal and ventral divisions.  Dorsal divisions L2 and L3 from the 
lateral cutaneous nerve of the thigh and L2,L3,L4 form the femoral nerve. 
The ventral branches join to form the obturator nerve (L2,L3,L4) and when 
present accessory obturator nerve (L3,L4).
Course  of  the  ilioinguinal,  iliohypogastric,  genitofemoral 
nerves 
Ilioinguinal nerve  -  
It  emerges  at  the lateral  border  of  the psoas,  runs  downwards and 
laterally  in  front  of  the quadratus  lumborum,  and behind the kidney and 
colon, pierces the transverses abdominis a little above the iliac crest,  and 
runs in the abdominal wall.  It pierces the internal oblique just below and 
medial to the iliohypogastric nerve, runs with the spermatic cord or with the 
round ligament of the uterus, and becomes cutaneous by emerging through 
the superficial inguinal ring.
Iliohypogastric nerve  -  
It has a similar course as the ilioinguinal nerve except it is a higher 
level.  The iliohypogastric nerve pierces the internal oblique from deep to 
superficial surface about 2.5 cm in front of the anterior superior iliac spine. 
It becomes cutaneous by piercing the external oblique aponeurosis about 2.5 
cm above the superficial inguinal ring.  Its lateral cutaneous branch supplies 
the gluteal region.
Genitofemoral nerve  -  
It emerges on the anterior surface of the psoas muscle near its medial 
border and runs downwards in front of the muscle.  Near the deep inguinal 
ring, it lies in front of the external iliac artery and divides into femoral and 
genital branches.  The femoral branch passes through the arterial 
compartment of the femoral sheath and is distributed to the skin of the upper 
part of the front of the thigh.  The genital branch pierces the psoas sheath 
and enters the inguinal canal through the deep inguinal ring.  In the male, it 
supplies the cremaster muscle, and in the female, it gives sensory branches 
to the round ligament of the uterus and to the skin of the labium majus.
Course of the ilioinguinal, iliohypogastric and genitofemoral 
nerves
PHARMACOLOGY
LIGNOCAINE
Amide  local  anaesthetic  which works rapidly  and reliably.   It  was 
synthesized by Lofgren in 1943.  Its chemical structure is 2, 6 aceto xylidide 
hydrochloride.
Physiochemical properties  - 
 Molecular weight  -  234 
 pKa  -  7.9
 Partition Coefficient  -  2.9
 Binds to alpha – 1 acid glycoprotein  -  64 %
Pharmacokinetics  -  
Lignocaine is metabolized in liver by microsomal enzymes.  N – 
dealkylation of the tertiary amine takes place and hydroxylation of  aromatic 
nucleus occurs.  Lignocaine is broken down to xylidide and diethyl 
aminoacetic acid.  Excreted in urine as xylidide and 5 % unchanged form. 
At body pH of 7.4, lignocaine with pKa 7.9, 25 % exists in non – ionized 
state.  Peak plasma concentration is achieved within 15 – 20 mins.  Volume 
of distribution is 9 litres.  It has medium potency, rapid onset of action, good 
penetrance and medium duration of action.  If epinephrine 5 micrograms/ml 
is added, it prolongs the duration  and reduces the toxicity.
Pharmacodynamics  -  
 CVS  -   Lignocaine  binds  to  cardiac  sodium channels  and causes 
inhibition of conduction and it comes out of it quickly.  In low doses, 
it  is  used  to  treat  ventricular  arrhythmias.   It  increases  pulmonary 
artery  pressure  and  has  a  negative  inotropic  effect.   May  cause 
bradyarrhythmias in high doses.
 CNS  -  Stabilizes the cell membrane.  So, used in treating grand mal 
seizures.
 Smooth  muscle   -   It  is  stimulating  at  low  concentrations  and 
inhibitory at high concentrations.
 Anti – inflammatory property  -  It inhibits prostaglandins synthesis 
and migration granulocytes.
Mode of action  -  
Lignocaine  prevents  transmission  of  nerve  impulses  by  inhibiting 
passage  of  sodium ions  through  ion  selective  sodium channels  in  nerve 
membrane.
Uses  -  
 For alteration of stress response to intubation
 Suppression of grand mal seizures
 Analgesia
 Treatment of ventricular dysrrhythmias
Systemic toxicity  -  
 The ratio of dosage required for irreversible cardiovascular collapse 
and the dosage that  produces CNS toxicity,  i.e.,  CVS/CNS ratio is 
lower for lignocaine  -  7:1.
 Neurotoxicity  -  Transient radicular irritation
BUPIVACAINE
Amide local anaesthetic which is available as racemic mixture of the 
enantiomers.  It was introduced in 1957.  Its chemical structure is N – Butyl 
pipecolic 2,6 dimethyl xylidide hydrochloride.  
Physiochemical properties  -  
 Molecular weight 288
 pKa 8.1
 Partition coefficient 27.5
 Protein binding 96 %
Pharmacokinetics  -  
 Absorption   -   Depends  on  the  site  of  injections  and  presence  of 
vasoconstrictors.
 Distribution   -   Highly  perfused  organs  (brain,  heart,  lung)  are 
responsible  for  initial  uptake,  followed  by  slower  redistribution  to 
moderately  perfused  tissues.   Depends  on  tissue  blood  partition 
coefficient.  High lipid solubility facilitates tissue uptake.
 Metabolism and Excretion  -  Metabolised by microsomal enzymes of 
liver  by  amine  hydrolysis  and  conjugation  and  aromatic 
hydroxylation.  So, metabolism is affected by hepatic disorders.
Pharmacodynamics  -  
 CVS  -   Hypotension,   AV block,  dysrrhythmias.   It  causes  more 
pronounced depolarization than lignocaine and blocks cardiac sodium 
channels and alters mitochondrial function, it goes in fast but comes 
out  slow,  so  highly  cardiotoxic.   Resuscitation  is  prolonged  and 
difficult.
 RS  -  Relaxes smooth muscles of bronchioles
 Musculoskeletal  -  If the drug is directly injected into the muscle, the 
drug is myotoxic.
 CNS   -   At  toxic  doses,  it  can  cause  tinnitus,  blurred  vision, 
restlessness, agitation, blurred speech, drowsiness and coma.
 Hematological  -  It enhances fibrinolysis.
Mode of action  -  
Bupivacaine  acts  by  binding  to  voltage  gated  sodium  channels, 
prevents  opening  of  channels  by  inhibiting  conformational  changes  that 
underlie channel activation.
Onset and Duration of Action  -  
Slow and prolonged duration.  Duration of action also depends on the 
dose and concentration of drug injected.   Epinephrine does not markedly 
prolong the duration.
GLYCOPYRROLATE
Physiochemical properties –
Glycopyrrolate is  an ester linkage between an aromatic acid called 
mandelic  acid  and  an  organic  base  called  tropine.   Active  form of  this 
anticholinergic drug is the levorotatory form.
Pharmacokinetics –
 Onset of action  -  2 to 3 minutes
 Duration of action  -  2 to 4 hours
 Elimination  -  80 % is excreted unchanged in the urine
Pharmacodynamics  -  
 Anti-sialagogue – More potent than atropine, but slightly less potent 
than scopolamine
 CVS – Increases heart rate
 CNS – Due to its quarternary structure, it does not penetrate the blood 
brain barrier and there are no CNS effects
 Smooth Muscle – Relaxes smooth muscle
Dose –
 Premedication – 5 to 10 micrograms/kg iv or im
FENTANYL
Physiochemical properties – 
It is a synthetic opioid coming under the class of phenylpiperidine 
series.
Pharmacokinetics - 
 Onset of action – Within 1 to 1.5 mins. Since it is highly lipid soluble, 
it is rapidly eliminated from the central tissues like brain, heart and 
lung and get redistributed to muscle and fat within 5 mins. 
 Duration of action – Recovery from fentanyl action occurs within 60 
mins. But, terminal elimination half-life is upto 3.5 to 6 hours.
 Elimination  –  Clearance  is  primarily  by  rapid  and  extensive 
metabolism in the liver.
Pharmacodynamics –
 CVS  –  At  usually  used  clinical  doses,  remarkable  hemodynamic 
stability.  Only at very high doses, slight negative inotropic property. 
When used in combination with other drugs like diazepam, fentanyl 
exhibited cardiovascular depression.
 RS – Respiratory depression develops rapidly after fentanyl injection, 
reaching a peak within 5 minutes.
 CNS – Reduces the MAC of volatile anaesthetics in a dose-dependent 
manner.  There are some case reports of increased ICP and CBF.  But, 
the reason was found to be due to decreased mean arterial pressure 
which led to increase in CBF AND ICP.  
 Smooth  muscle  –  Can  delay  gastric  emptying  and  significantly 
increases common bile duct pressure.
Dose - 
1.5 to 2 mics/kg prior to induction agent like barbiturate.  0.5 to 2.5 
mics/kg  may  be  repeated  every  30  mins  depending  upon  the  surgical 
stimulus. 
PROPOFOL
Physiochemical properties –
Propofol is 2,6 – diisopropylphenol consisting of a phenol ring with 
two isopropyl groups attached.  The preparation consists of a 1 % aqueous 
solution with soyabean oil, glycerol and egg lecithin.  
Pharmacokinetics – 
 Onset of action – Highly lipid soluble, so onset of action is one-arm- 
to-brain circulation time. 
 Duration of action – Awakening from propofol is also very rapid due 
to a very short initial distribution half-life of about 2 to 8 mins.
 Elimination – Exceptionally rapid clearance rates, 10 times faster than 
thiopental,  probably  accounting  for  the  rapid  recovery  after  a 
continuous infusion.  Metabolites of propofol are primarily excreted in 
the urine.
Pharmacodynamics - 
 CVS – Decreases systemic vascular  resistance,  cardiac contractility 
and preload causing a decrease in blood pressure.
 RS – Profound respiratory depressant that usually causes apnea on 
induction.
 CNS – Reduces cerebral blood flow and intracranial pressure.
Dose –
Induction dose of 1 to 3 mg/kg.  Maintenance infusion of 50 to 200 
mics/kg/min.
MIDAZOLAM
Physiochemical properties –
It is a water soluble benzodiazepine with an imidazole ring in its structure 
that accounts for stability in aqueous solutions and rapid metabolism.
Pharmacokinetics – 
 Onset of action – 30 to 60 secs.  Time to peak effect – 3 to 5 mins.
 Duration of action – It is a much shorter acting drug than diazepam 
and the elimination half-life is about 1 to 4 hours
 Elimination  –  Metabolised  by  cytochrome  P-4503A4 enzymes.   It 
undergoes  hydroxylation  and  subsequent  glucuronidation  and  is 
finally eliminated by the kidneys.
Pharmacodynamics –
 CNS  –  Produces  sedation,  hypnosis  and  also  has  anticonvulsant 
properties.
 CVS – At low doses, relatively stable even when used with opioids. 
At high doses, especially in the elderly can cause hypotension.
 RS – Dose-dependent  respiratory  depression  can occur.   Transient 
apnea can occur with rapid iv injection of large doses of midazolam.
Dose –
1 to 2.5 mg iv as premedicant, or as sedation during regional anaesthesia.
REVIEW OF LITERATURE
Innumerable studies have been done by various workers on the type of 
anaesthesia  for  inguinal  hernia  repair.   Dajun  Song,  MD,  PhD  et  al  compared  the 
recovery profiles  and costs  of  anaesthesia  for  outpatient  unilateral,  inguinal  hernia 
repair and concluded that local anaesthesia with mild sedation resulted in 
greater  patient  satisfaction,  lower  pain  scores  and  quicker  time-to-home 
readiness.
A multicentre randomized trial by Nordin P et al also reiterated the 
fact  that  local  anaesthesia  has  substantial  advantages  over  general 
anaesthesia because of lesser postoperative pain and shorter requirements of 
hospital stay.
Similar  results  were  reported  by  Aasbo  V  et  al  when  comparing 
inguinal field block with general anaesthesia.  
Subramaniam P et  al  conducted a  study comparing inguinal  hernia 
repair between local and general anaesthesia and concluded that the post-op 
parenteral  opioid  requirements  was  significantly  lower  in  the  local 
anaesthesia group.
A study conducted by Behnia et al found that there was no significant 
hemodynamic  differences  between  local  anaesthesia  group  and  general 
anaesthesia group. But, the pain medication required for post-op pain relief 
was considerably lesser in the local group and significant cost benefits were 
seen in the local group because of elimination of general anaesthesia and 
reduction of recovery room fees.
Mark Tverskoy et al conducted a randomised, double blind study and 
concluded  that  post-operative  pain  was  significantly  decreased  when 
inguinal hernia repair was done under local anaesthesia.  The most quoted 
study for inguinal field block which advocates the combination of lignocaine 
and bupivacaine is “Local Anaesthesia for Inguinal Hernia Repair Step by 
Step Procedure” by Amid et al published in the Annals of Surgery in 1994. 
When  comparing  the  pharmacokinetics  and  pharmacodynamics  of 
lignocaine and bupivacaine, it is easy to understand the reason behind using 
a combination of the two when we are using it for the inguinal block.  In 
addition, various studies have been performed to evaluate the efficacy and 
usefulness  of  combination  of  lignocaine  and  bupivacaine  for  peripheral 
nerve blocks.
MATERIALS AND METHODS
A prospective, randomized study was conducted on 40 patients 
coming for  inguinal hernia repair.  They were randomly allocated into either 
local  anaesthesia group or general anaesthesia group by flip of a coin. 
Study  conducted after approval of institutional ethical committee and 
informed consent from the patient.
Inclusion Criteria:
 ASA Status I & II
 Age 18 to 65 years
 Weight 50 to 70 kg
 Elective procedure
 Unilateral, reducible inguinal hernia
 Mallampati Class I and II
 Mouth opening > 3 cm
 Neck movements adequate
Exclusion Criteria:
 Patient refusal
 Active  gastroesophageal  reflux  disease  or  other  predisposing 
conditions for possible aspiration
 Significant neurological, psychiatric, cardiovascular, respiratory, renal 
or hepatic disease
 Any signs or conditions indicating anticipated difficult airway
 Not fulfilling inclusion criteria
Procedure for Group L  -  Local Anaesthesia:
 Premedication  -   Glycopyrrolate 0.2mg iv
Fentanyl 2 micrograms/kg iv
 20 ml of 2%lignocaine + 20 ml of 0.5% bupivacaine with 100 
micrograms adrenaline is taken
 Midazolam titrated to Ramsay Sedation Score of 3 (max dose of 0.1 
mg/kg)
 Supplementation of local anaesthetic allowed intraoperatively by 
surgeon
 Maximum  dose  of  lignocaine  with  adrenaline  is  500  mg 
Maximum dose of bupivacaine with adrenaline is 225 mg
 Technique  -  
Skin wheals with 25 G needle at 
(A)  -  2 cm medial and inferior to anterior superior iliac spine
(B)  -  superficial inguinal ring
23 G Quincke’s needle is introduced at (A) in a lateral and inward 
direction so as to touch the iliac crest.  On its way out, the needle is moved 
in a fan- shaped manner for even spread in all the layers.  Around 10 ml of 
local anaesthetic is injected in this manner.  Through the same skin wheal, 
the  needle is introduced medially, parallel to and above the inguinal 
ligament around the anticipated line of incision, with around 5 ml of local 
anaesthetic.  
23 G Quincke’s needle is introduced at (B) in a medial and downward 
direction  so  as  to  touch  the  pubic  symphysis.   Around  5  ml  of  local 
anaesthetic is injected here.  Through the same skin wheal,  the needle is 
introduced laterally, parallel to and above the inguinal ligament around the 
anticipated line of incision, with around 5 ml of local anaesthetic.  Through 
the same skin wheal,  the needle is introduced towards the umbilicus and 
around 10 ml of local anaesthetic is injected subcutaneously.
5 ml of local anaesthetic is kept which can be used intraoperatively by 
the surgeon.  Once the spermatic cord is exposed, if there is any traction 
pain, around 5 ml of local anaesthetic is injected under direct vision at the 
deep inguinal ring by the surgeon to anaesthetize the genitofemoral nerve 
and sympathetic fibres around the cord.
 Sensory block is assessed by ether-soaked cotton at the operative site.
 Analgesic  failure  is  managed  with  general  anaesthesia  and  these 
patients are excluded from the study.
 Intraoperatively,  patients  receive  supplemental  oxygen,  midazolam, 
and intravenous fluids.
 Heart Rate, NIBP, O2 Saturation, Sedation Score are measured every 
5 mins till the end of the procedure.
Procedure for Group G  -  General Anaesthesia
 Premedication  -   Glycopyrrolate 0.2 mg iv
Fentanyl 2 micrograms/kg iv
 Induction  -  Preservative-free lignocaine 1.5 mg/kg iv
  Propofol 3 mg/kg iv
 Insertion of 4 Size Classical LMA
 Maintenance  -   N2O : O2  =  66 : 33
       Sevoflurane 0.5 to 2 %
       Intravenous fluids
 HR, NIBP, O2 Saturation are recorded every 5 mins till the end of the 
procedure
 LMA is removed after patient is fully awake
Post-operative Analgesia:
 Both  the  groups  receive  uniform  analgesia  –  Tablet  Diclofenac 
Sodium 50 mg bd.
 Rescue analgesia – In case patient complains of pain or the score in 
the  Visual  Analog  Score  is  in  the  moderate  range,  Injection 
Pentazocine 0.6 mg/kg.
Parameters that are compared:
 Intra-operative events like HR, NIBP, O2 Saturation.
 Recovery time based on Modified Aldrete Score
 Post-op pain scores based on Visual Analog Scale at 6 hours at rest 
and during movement and at 24 hours at rest and during movement.
 Patient  satisfaction  with  the  mode  of  anaesthesia  asked at  24hours 
rated as poor, average, good, excellent.
 Post-op  side  effects  like  nausea,  vomiting,  backache,  headache, 
pruritis,  sore  throat,  urinary  retention,  wound  infection,  wound 
hematoma.
VISUAL ANALOG SCALE
RAMSAY SEDATION SCORE
1.     Patient is agitated and anxious or restless, or both
2.     Patient is co-operative, oriented and tranquil
3.     Patient responds to commands only
4. Patient exhibits brisk response to light glabellar tap or loud auditory 
stimulus
5.     Patient exhibits sluggish response to light glabellar tap or loud 
auditory stimulus
6     Patient exhibits no response
MODIFIED ALDRETE SCORING SYSTEM
Activity: able to move, voluntarily or on command
2  -  Four extremities
1  -  Two extremities
0  -  No extremities
Respiration
2  -  Able to breathe deeply and cough freely
1  -  Dyspnea, shallow or limited breathing
0  -  Apnea
Circulation
2  -  Blood pressure within 20 mm Hg of preoperative level
1  -  Blood pressure within 20 – 50 mm Hg of preoperative level
0  -  Blood pressure + or – of preoperative level
Consciousness
2  -  Fully awake
1  -  Arousable on calling
0  -  Unresponsive
Oxygen saturation
2  -  Saturation > 92%   
1  -  Needs oxygen to maintain saturation > 90%
0  -  Saturation < 90% with oxygen
STATISTICS
Statistical methods used
The descriptive statistics of the variables studied are represented as 
two-way tables. The categorical factors are represented by the number and 
frequency (%) of cases. The continuous variables are represented by 
measures of central frequency (like mean, median & mode) and deviation 
(standard deviation and range). The differences in the proportions are tested 
for statistical significance using non-parametric Chi-square test for variables 
measured on nominal scale. Fisher’s exact probability test was employed 
wherever required. For variables measured on a continuous scale, when 
testing for two groups, Student “t” test is used to test for statistical 
significance in the differences of the two means.
TABLE - 1
Distribution of cases by patient satisfaction and group
Subjective rating 
of patient 
satisfaction
Group G 
(n=20)
Group L 
(n=20) p-value
No. % No. %
Good
Others
6
14
30.0
70.0
13
7
65.0
30.0
0.03
The frequency of cases whose subjective rating of satisfaction as 
“Good” was more among Group L than Group G and the difference was 
statistically significant (p=0.03). 
TABLE - 2
Distribution of cases by rescue analgesia and group
Rescue analgesia
Group G 
(n=20) Group L(n=20) Total
No. % No. % No. p-value
Category 1 11 78.6 3 21.4 14 0.05
Category 2 4 66.7 2 33.3 6 N.S
Among  the  rescue  analgesia  category  coded  as  1  (n=14),  the 
distribution of  the number of cases was more among Group G (79%) than 
Group  L  (21%)  and  the  difference  was  statistically  significant  (p=0.05). 
Among the rescue analgesia category coded as 2 (n=6), the distribution of 
the number of cases was more among Group G (67%) than Group L (33%). 
However, the difference was statistically not significant.
TABLE – 3
Distribution of cases by post OP side-effects and group
Complications
Group G 
(n=20)
Group L 
(n=20) p-value
No. % No. %
Nil
Headache only
Sore throat only
Nausea+Vomiting
Nausea+Vomiting+S
Pruritis
15
0
1
3
1
0
75.0
0.0
5.0
15.0
5.0
0.0
18
1
0
0
0
1
90.0
5.0
0.0
0.0
0.0
5.0
N.S
The distribution of the number of cases reporting no post-OP side-
effects  was more among Group L (90%) than Group G (75%). However, the 
difference was not statistically significant. 
TABLE - 4
Distribution of cases by post-OP pain assessment at 6-hours
Post OP pain 
assessment category: 
at 6-hours
Group G 
(n=20)
Group L 
(n=20) p-value
No. % No. %
At rest
   2
   3
   4
2
15
3
10.0
75.0
15.0
16
4
0
80.0
20.0
0.0
<0.001
At movement
   2
   3
   4
   5
1
5
12
2
5.0
25.0
60.0
10.0
9
9
2
0
45.0
45.0
10.0
0.0
0.001
The differences in the frequency of cases by post-OP pain assessment 
category at 6-hours between Group G and Group L were statistically 
significant at rest (p<0.001) and at movement (p=0.001). 
TABLE - 5
Distribution of cases by post-OP pain assessment at 24-hours
Post OP pain 
assessment category: 
at 24-hours
Group G 
(n=20)
Group L 
(n=20) p-value
No. % No. %
At rest
   2
   3
   4
1
13
6
5.0
65.0
30.0
4
15
1
20.0
75.0
5.0
0.06
At movement
   2
   3
   4
1
12
7
5.0
60.0
35.0
3
15
2
15.0
75.0
10.0
0.13
 
The differences in the frequency of cases by post-OP pain assessment 
category at 24-hours between Group G and Group L were statistically not 
significant at rest (p=0.06) and at movement (p=0.13). 
TABLE - 6
Distribution of recovery time of cases by groups
Age Group G Group L p-value
No. of cases
Mean
S.D.
Median
Range
20
5.6
1.28
5.5
3 – 8
20
1.4
0.59
1
1 - 1
<0.001
 
The mean recovery time was observed to be lesser in Group L than 
Group G, the difference being statistically significant (p<0.001).
TABLE – 7
Distribution of values by groups and MAP values
MAP at different times
Group G
(n=20)
Group L
(n=20)
p-value
0- min
Mean
SD
92.4
7.99
93.3
7.03
0.71
5- min
Mean
SD
91.3
8.59
92.1
7.65
0.54
10- min
Mean
SD
89.2
7.64
91.6
7.69
0.33
15-min
Mean
SD
89.1
7.21
90.9
6.28
0.41
20-min
Mean
SD
88.2
7.37
89.8
6.90
0.48
25-min
Mean
SD
88.2
7.28
90.1
6.65
0.42
30-min 
Mean
SD
88.0
7.75
90.7
6.60
0.24
The mean MAP values were generally higher among Group L than 
Group G at all the time points studied. However, the differences were not 
statistically  significant. The trend of mean values of MAP with increasing 
time points was generally decreasing with a tendency to taper off at the end. 
TABLE - 8
Distribution of values by groups and pulse values
MAP Group G
(n=20)
Group L
(n=20)
p-value
0- min
Mean
SD
76.7
6.52
77.5
6.96
0.71
5- min
Mean
SD
75.8
6.68
77.2
5.96
0.49
10- min
Mean
SD
73.5
6.15
75.4
6.74
0.36
15-min
Mean
SD
73.4
5.70
75.1
6.03
0.37
20-min
Mean
SD
70.4
4.24
75.3
5.21
0.002*
25-min
Mean
SD
70.9
4.83
75.3
5.74
0.01*
30-min 
Mean
SD
70.0
4.86
75.8
6.65
0.003*
35-min 
Mean
SD
69.7
4.56
73.2
4.41
0.02*
The mean values were generally higher among Group L than Group G 
at all the time points studied. However, the differences were statistically 
significant only from 20 minutes and later and not at the rest of the time 
points studied. The trend of mean values of pulse rate with increasing time 
points was generally decreasing with minor fluctuations among both groups. 
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DISCUSSION
The  observations  and  results  show  a  clear  benefit  from  local 
anaesthesia for inguinal hernia repair.
Local anaesthesia provides the following advantages
• Good patient satisfaction
• No major hemodynamic changes in the intra-op period
• Quicker recovery time
• Lower pain scores in the immediate post-op period, upto 6 hours
• Less post-op opioid requirements, so better pain relief
• No major post-op side effects 
General anaesthesia has the following main disadvantages
• Prolonged recovery time
• Decreased duration of post-op pain relief
• Increased post-op opioid requirements as rescue analgesia
SUMMARY
This study was conducted in unilateral  inguinal hernia repairs as a 
comparative, randomized, prospective study between local anaesthesia and 
general anaesthesia.   Taking into account inclusion criteria and exclusion 
criteria,  the  patients  were  randomly  divided  into  local  anaesthesia  and 
general  anaesthesia  groups.   The  procedures  for  each  group  was 
meticulously  followed  and  the  patients  followed  up  for  24  hours.   The 
parameters  that  were  compared  in  the  study  were  noted  down  for  each 
patient and the results computed using relevant statistical tests.
CONCLUSION
Based on the parameters compared and the statistical analysis results, 
it is  seen that inguinal hernia repair under local anaesthesia is better because 
it  provides better recovery, better post-op pain relief and good patient 
satisfaction.
The conclusions from this study is inguinal hernia repair done under 
local anaesthesia with ilio-inguinal, iliohypogastric nerve blocks with field 
block is a very effective and attractive alternative to general anaesthesia.
PROFORMA
Name :
Age :
Sex :
Height :
Weight :
ASA :
Study Group :
Hospital No. :
Date :
Diagnosis :
Operative procedure :
General Examination
GC :
CVS :
RS :
PR :
BP :
Airway – MPC :
     Mouth opening :
     Neck movements :
Routine Investigations
Hb          PCV
Blood –  Urea                   Sugar
Serum – Creatinine          Electrolytes
Intra-op Events
TIME PR MAP SpO2 Ramsay 
Score
0 min
5 min
10 min
15 min
20 min
25 min
30 min
35 min
40 min
45 min
50 min
55 min
60 min
Recovery Time ( Based on Modified Aldrete Score )
Time for Score of greater than or equal to 9
Post-op Pain Scores ( Based on Visual Analog Scale 
At 6 hours – Rest
       Movement
At 24 hours – Rest
         Movement
Patient Satisfaction
Poor
Average 
Good
Excellent
Post-op Side Effects
Nausea
Vomiting
Headache
Pruritis
Sore throat
Urinary retention
Wound infection
Wound hematoma
MASTER CHART
GROUP L – LOCAL ANAESTHESIA
S.No. Parameter
s
0 5 10 15 20 25 30 35 40 45 50 55 60
1 Pulse
MAP
RSS
80
93
2
76
90
2
75
90
3
75
88
3
76
90
3
75
88
3
75
90
3
76
88
2
70
88
2
76
94
2
2 Pulse
MAP
RSS
84
84
2
76
85
2
68
84
2
70
86
2
72
80
3
80
82
2
76
80
3
72
84
2
80
83
2
78
85
2
3 Pulse
MAP
RSS
74
100
2
76
98
2
67
98
2
67\
98
2
69
94
2
72
94
2
70
96
3
69
94
3
76
98
2
72
94
2
72
98
2
76
102
2
76
101
2
4 Pulse
MAP
RSS
77
98
2
86
102
2
78
98
3
72
97
3
80
97
3
72
98
3
90
104
3
72
94
2
76
94
2
75
96
2
76
96
2
75
98
2
5 Pulse
MAP
RSS
70
93
2
72
92
2
70
90
3
68
93
3
72
90
3
72
86
3
76
90
2
72
86
2
72
88
2
6 Pulse
MAP
RSS
86
100
2
80
100
2
70
96
2
72
92
3
76
96
3
70
100
3
72
92
3
68
96
3
72
92
2
72
94
2
76
92
2
7 Pulse
MAP
RSS
86
83
2
86
83
2
92
80
3
90
81
3
84
75
3
86
77
3
90
81
3
86
80
3
8 Pulse
MAP
RSS
70
107
2
76
106
2
82
106
2
76
100
3
72
94
3
66
94
3
78
96
3
72
102
3
76
106
2
72
102
2
70
102
2
9 Pulse
MAP
RSS
86
99
2
86
102
2
82
104
2
78
98
3
82
99
3
82
98
3
80
99
3
78
98
2
78
98
2
80
98
2
10 Pulse
MAP
RSS
70
89
2
76
80
2
78
84
2
78
84
2
76
84
3
76
84
3
76
84
2
78
86
2
70
86
2
76
84
2
76
84
2
11 Pulse
MAP
RSS
76
88
2
76
88
2
70
88
2
70
86
2
72
86
3
72
85
3
72
86
2
72
86
2
72
86
2
12 Pulse
MAP
RSS
78
86
2
78
89
2
78
90
2
76
86
3
76
86
3
76
86
3
72
86
3
70
86
3
76
88
2
78
88
2
76
88
2
13 Pulse
MAP
RSS
72
86
2
72
86
2
70
80
2
72
82
2
70
84
3
70
84
3
66
84
2
70
80
3
72
86
2
70
86
3
70
86
3
72
85
3
14 Pulse
MAP
RSS
72
97
2
72
97
2
76
96
2
80
97
2
72
95
2
76
96
2
76
96
2
76
95
2
72
97
2
76
95
2
72
97
2
76
95
2
70
96
2
15 Pulse
MAP
RSS
76
93
2
76
90
2
72
90
2
70
92
2
72
92
3
76
90
3
72
90
3
72
92
2
72
90
2
76
90
2
76
90
2
72
92
2
16 Pulse
MAP
RSS
78
93
2
78
93
2
76
90
2
70
90
3
72
91
3
76
91
2
72
92
2
76
91
2
78
91
2
78
91
2
76
92
2
76
91
2
17 Pulse
MAP
RSS
94
105
2
90
105
2
88
102
2
88
101
2
90
102
2
90
101
3
88
100
3
76
98
3
76
98
3
76
98
2
80
99
2
76
78
2
18 Pulse
MAP
RSS
78
89
2
76
89
2
76
88
2
78
85
2
76
85
2
76
86
2
70
86
3
72
86
3
72
85
2
76
86
3
76
86
2
19 Pulse
MAP
RSS
76
98
2
70
98
2
72
96
2
76
95
2
76
94
3
72
95
3
72
95
3
72
95
3
76
95
3
76
95
3
74
95
3
75
93
3
20 Pulse
MAP
RSS
66
85
2
66
85
2
68
82
2
76
86
3
72
82
3
70
86
3
72
86
3
66
76
2
66
80
2
68
95
2
60
85
2
S.No.
Recovery 
Time
In mins
Postop Pain 
Scores
At 6 hours
Postop Pain 
Scores
At 24 hours
Patient
Satisfactio
n
Rescue
Analgesia
Iv 
Pentazocine
(0.6 mg/kg)
No of times
Postop
Side 
Effects
Rest Movemen
t
Rest Movemen
t
1 1 2 2 3 3 Good Nil
2 2 2 4 2 2 Average 1 Nil
3 1 3 3 3 3 Average Nil
4 1 2 2 2 2 Average Nil
5 1 2 2 3 3 Good 2 Pruritis
6 1 2 2 3 3 Good Nil
7 3 2 2 2 2 Good Nil
8 1 2 3 3 3 Average Nil
9 2 2 2 3 3 Average Nil
10 1 2 3 3 4 Good 1 Nil
11 1 2 3 3 3 Good Nil
12 1 2 3 2 3 Good Nil
13 1 3 3 4 4 Poor 2 Nil
14 2 2 2 3 3 Good Nil
15 2 3 3 3 3 Average Nil
16 1 2 2 3 3 Good Headache
17 1 2 4 3 3 Good 1 Nil
18 2 3 3 3 3 Good Nil
19 2 2 3 3 3 Average Nil
20 1 2 2 3 3 Good Nil
GROUP G – GENERAL ANAESTHESIA
S.No. Parameter
s
0 5 10 15 20 25 30 35 40 45 50 55 60
1 Pulse
MAP
85
88
74
88
74
84
72
82
76
82
82
84
76
84
72
83
72
84
76
84
76
84
2 Pulse
MAP
82
86
80
88
76
84
76
83
72
83
70
83
72
84
72
84
70
80
70
83
72
82
72
83
76
84
3 Pulse
MAP
68
86
66
84
72
82
68
84
70
82
76
86
70
82
68
80
72
82
70
84
68
84
4 Pulse
MAP
70
99
78
102
82
102
78
99
70
98
70
98
66
102
68
99
70
98
72
98
72
98
70
98
5 Pulse
MAP
90
107
90
107
82
104
82
102
80
102
80
102
78
104
80
102
80
102
6 Pulse
MAP
78
87
76
87
70
85
72
85
66
84
70
85
68
85
70
84
72
84
70
84
70
84
7 Pulse
MAP
80
90
76
88
70
90
72
92
70
88
68
86
70
85
72
84
70
85
70
85
66
84
70
85
8 Pulse
MAP
84
107
86
106
78
96
76
95
76
96
76
96
78
95
76
96
70
95
76
95
76
96
78
98
9 Pulse
MAP
70
108
68
106
70
104
78
104
66
104
68
104
70
104
70
102
70
102
70
104
10 Pulse
MAP
84
96
84
96
72
90
76
88
72
90
72
90
72
88
74
88
74
90
72
88
72
90
74
90
11 Pulse
MAP
72
93
72
93
70
90
70
92
72
93
70
90
68
90
68
90
68
88
72
90
70
90
12 Pulse
MAP
80
93
78
88
80
86
76
86
72
86
72
86
72
86
72
86
76
86
76
86
13 Pulse
MAP
78
89
76
89
76
86
72
84
70
84
66
84
66
84
66
84
68
84
70
86
70
86
14 Pulse
MAP
78
90
76
90
70
88
66
90
66
88
68
92
66
86
66
86
68
86
66
85
66
85
15 Pulse
MAP
70
90
78
86
86
92
86
92
70
86
74
86
74
86
72
85
72
86
74
86
74
86
72
85
70
92
16 Pulse
MAP
66
81
60
81
58
82
60
81
60
80
62
80
60
78
60
80
62
78
17 Pulse
MAP
70
80
72
79
70
79
70
80
70
78
66
76
62
78
62
76
62
76
66
76
60
76
18 Pulse 74 74 74 72 72 72 74 70 70 70 72 74
MAP 90 90 82 84 84 83 83 84 83 84 84 83
19 Pulse
MAP
76
90
76
80
70
82
76
82
70
82
68
82
66
83
66
83
66
84
68
86
20 Pulse
MAP
78
98
76
98
70
96
70
96
68
94
68
92
72
92
70
92
70
93
70
93
72
94
70
94
S.No
.
Recovery 
Time
In mins
Postop Pain 
Scores
At 6 hours
Postop Pain 
Scores
At 24 hours
Patient
Satisfactio
n
Rescue
Analgesia
Iv 
Pentazocine
(0.6 mg/kg)
No of times
Postop
Side 
Effects
Rest Movement Rest
Movemen
t
1 4 3 4 3 3 Average Nil
2 8 3 4 3 3 Good 1 Nausea
Vomiting
3 7 4 4 3 4 Poor 1 Nausea
Vomiting
Sore 
throat
4 5 3 4 3 3 Average Nil
5 6 4 4 3 3 Average 2 Nausea
Vomiting
6 5 2 3 2 2 Excellent Nil
7 7 3 4 3 3 Good Nil
8 6 4 4 3 3 Average Nil
9 6 3 3 3 3 Average 2 Nil
10 5 3 4 4 4 Average 1 Nil
11 7 3 3 4 4 Average 2 Nil
12 3 3 3 3 3 Good Nil
13 5 3 4 3 3 Average Nil
14 4 2 2 3 3 Average 1 Nil
15 5 3 4 3 3 Good Nil
16 6 3 4 4 4 Good Nil
17 5 3 5 4 4 Average 1 Nausea
Vomiting
18 4 3 4 4 4 Average 1 Sore 
Throat
19 7 3 5 4 4 Average 2 Nil
20 6 3 3 3 3 Good 1 Nil
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